Home > Boards > US OTC > Medical - Drugs > OncBioMune Pharmaceuticals Inc. (OBMP)

a. increasethe Company’s authorized common stock,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
BooDog Member Profile
 
Followed By 179
Posts 19,122
Boards Moderated 4
Alias Born 08/03/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 5:17:01 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/15/2019 2:23:24 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/15/2019 2:14:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 1:52:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/18/2019 4:58:08 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/29/2019 1:09:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 5:44:06 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 5/13/2019 5:16:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 5:02:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 6:00:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 6:00:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 5:59:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 5:57:05 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 4/30/2019 3:27:08 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:36:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 8:56:51 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:59:06 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:54:10 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 3/14/2019 5:53:43 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:51:30 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:48:31 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 3/14/2019 5:47:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:46:12 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 3/6/2019 6:16:40 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 2/22/2019 5:30:17 PM
BooDog   Tuesday, 05/14/19 06:54:47 AM
Re: None
Post # of 9123 
a. increasethe Company’s authorized common stock, par value $0.0001 per share (the “Common Stock”) from 1,500,000,000shares to 5,000,000,000 shares.

I've seen this sheet music before. However, if they prove the science and START BEING TRANSPARENT keeping the updates rolling, conference callS and maybe even surprises (good of course) then the massive dilution will be sucked right up by retail and we could actually see this in the mid .20's+.

Crickets? Nada, see ya at .0001.

https://ih.advfn.com/stock-market/USOTC/oncbiomune-pharmaceuticals-inc-OBMP/stock-news/79902860/information-statement-all-other-definitive-def-1

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist